Popular / View All Posts

cAMPfire Stories: Two Old Friends, One New Pathway, and the Future of Vitiligo

| Dermatology Podcast Archives | No Comments

Guest: Dr. Jon Zippin What happens when two longtime friends, dermatologists, and self-proclaimed science nerds get together to talk about pigment? Well, this one time, at band cAMP…. Anyway, in…

cAMPfire Stories: Two Old Friends, One New Pathway, and the Future of Vitiligo

| Featured Articles, Featured Podcast, Global Steroidal Stewardship, Latest News, Podcast, Podcast Highlights | No Comments
Guest: Dr. Jon Zippin  What happens when two longtime friends, dermatologists, and self-proclaimed science nerds get together to talk about pigment? Well, this one time, at band cAMP…. Anyway, in...
Journal of Drugs in Dermatology JDD featuring Progression to Psoriatic Arthritis Among Psoriasis Patients Treated With JAK Inhibitors Compared With IL-17/23 Inhibitors

Progression to Psoriatic Arthritis Among Psoriasis Patients Treated With JAK Inhibitors Compared With IL-17/23 Inhibitors

| Featured Articles, Latest News | No Comments
Comparing Targeted Systemic Therapies and Incident Psoriatic Arthritis Risk in Psoriasis Patients  Have you read this article from the JDD? For dermatology providers managing complex psoriasis cases, predicting and mitigating...
Journal of Drugs in Dermatology JDD featuring Nordic European Countries Atopic Dermatitis (NECAD) I: Importance of Concordance With Skincare for Atopic Dermatitis

Nordic European Countries Atopic Dermatitis (NECAD) I: Importance of Concordance With Skincare for Atopic Dermatitis

| Atopic Dermatitis, Featured Articles, Latest News | No Comments
Optimizing Atopic Dermatitis Outcomes: Nordic Expert Panel Insights on Emollient Selection and Treatment Concordance Check out this groundbreaking publication featured in the Journal of Drugs in Dermatology. Managing chronic atopic...